Trouble Falling Asleep: What Could Be Causing It?

How Doctors Define "Trouble Falling Asleep"

Trouble falling asleep means your sleep-onset latency, the time from lights-out to sleep, consistently exceeds 20 to 30 minutes. A single bad night is normal. The problem becomes clinically significant when it occurs at least three nights per week and causes daytime impairment, a standard derived from the International Classification of Sleep Disorders, Third Edition (ICSD-3).

Sleep-Onset Latency vs. Sleep Maintenance

These two problems feel similar but have different biology. Sleep-onset insomnia (difficulty getting to sleep in the first place) is frequently driven by anxiety, circadian misalignment, or restless legs syndrome. Sleep-maintenance insomnia (waking during the night) more often reflects sleep apnea, pain, or alcohol use. Many patients have both, but identifying which came first guides therapy.

Acute vs. Chronic Presentations

Acute insomnia lasts fewer than three months and is usually tied to an identifiable stressor, illness, or life event. It resolves on its own in most cases. Chronic insomnia, defined as three or more months of symptoms on three or more nights per week, requires structured evaluation because spontaneous resolution becomes far less likely. The American Academy of Sleep Medicine's 2017 clinical practice guideline recommends CBT-I as the first-line treatment for chronic insomnia disorder in adults, ahead of any pharmacological approach.

Psychological Causes: The Most Common Culprit

Psychological factors account for the largest share of chronic sleep-onset insomnia in otherwise healthy adults.

Psychophysiological (Learned) Insomnia

This is the "vicious cycle" pattern. One or two difficult nights, often triggered by work stress or illness, condition the brain to associate the bedroom with wakefulness. The bed becomes a stimulus for arousal rather than sleep. Heart rate rises at bedtime. Thoughts accelerate. Each night reinforces the cycle.

A 2019 meta-analysis in Sleep Medicine Reviews found that cognitive arousal, defined as intrusive pre-sleep cognition, was the single strongest predictor of sleep-onset latency across 40 controlled studies. CBT-I directly targets this mechanism through stimulus control and sleep restriction.

Generalized Anxiety Disorder and Worry

Generalized anxiety disorder (GAD) makes the mind rehearse future threats during the quiet of bedtime. The DSM-5 lists sleep disturbance as one of six core GAD symptoms. Sleep-onset difficulty is more characteristic of anxiety-driven insomnia than early-morning awakening, which is more typical of depression.

Depression and Mood Disorders

Depression can cause either hypersomnia or insomnia, and the pattern varies by subtype. Atypical depression tends toward oversleeping. Melancholic depression classically causes early-morning awakening. Sleep-onset insomnia accompanied by low mood, anhedonia, or appetite change warrants a full mood screen before treating the sleep complaint in isolation.

Circadian Rhythm Disorders

Your circadian clock is a roughly 24-hour biological cycle governed by the suprachiasmatic nucleus in the hypothalamus. When that clock is misaligned with social or work schedules, falling asleep at the "right" time becomes genuinely difficult, not a matter of willpower.

Delayed Sleep Phase Disorder (DSPD)

People with DSPD have a naturally delayed circadian phase. They feel alert until 1 to 4 a.m. And, if allowed to sleep freely, wake at 10 a.m. To noon feeling refreshed. Forced early wake times for work or school create chronic sleep debt. DSPD affects an estimated 0.17% of adults but up to 7-16% of adolescents, according to ICSD-3 prevalence data reported by the American Academy of Sleep Medicine.

Treatment includes timed low-dose melatonin (0.5 mg taken 5 to 6 hours before the target sleep time), morning bright-light therapy with a 10,000-lux lamp for 30 minutes, and gradual chronotherapy.

Social Jet Lag and Irregular Sleep Schedules

Sleeping until noon on weekends and waking at 6 a.m. On Monday is the behavioral equivalent of flying from New York to London and back every week. The misalignment suppresses melatonin at the wrong times and makes Sunday-night sleep onset nearly impossible. A consistent wake time, seven days a week, is the single most effective circadian anchor.

Blue Light and Screen Exposure

Light in the 480-nm (blue) wavelength range suppresses melatonin via the retinohypothalamic tract. A Harvard-affiliated study published in PNAS demonstrated that two hours of evening tablet use at maximum brightness suppressed melatonin by 22%, shifted the circadian clock by 1.5 hours, and reduced REM sleep the following night. Amber-tinted screen filters and reducing screen brightness after 9 p.m. Produce measurable melatonin recovery.

Hormonal and Endocrine Causes

Hormones regulate the sleep-wake cycle at multiple points, and disruptions anywhere in that system can delay sleep onset significantly.

Perimenopause and Menopause

Estrogen and progesterone both have direct neurological effects on sleep. Progesterone, in particular, is a GABA-A receptor agonist, meaning it has a sedative quality. As progesterone falls during perimenopause, that natural sedative effect disappears. The 2023 Menopause Society Position Statement notes that 40-60% of perimenopausal women report sleep disturbance, with sleep-onset difficulty being among the most frequently cited symptoms.

Vasomotor symptoms (hot flashes and night sweats) compound the problem by raising core body temperature at a time when cooling is required for sleep onset. Hormone therapy, where clinically appropriate, reduces vasomotor frequency and duration and has shown secondary improvement in sleep-onset latency.

Thyroid Dysfunction

Hyperthyroidism produces a hyperadrenergic state: elevated heart rate, anxiety, heat intolerance, and an activated nervous system that resists sleep onset. A free T4 and TSH panel is a standard early step in any chronic insomnia workup where anxiety or palpitations are also present. Subclinical hyperthyroidism (TSH below 0.4 mIU/L with normal free T4) can also disrupt sleep without producing classic thyrotoxic symptoms.

Cortisol Dysregulation

The normal cortisol pattern peaks at approximately 8 a.m. And reaches its nadir around midnight. In people with hypothalamic-pituitary-adrenal (HPA) axis dysregulation, often seen in chronic stress, PTSD, or Cushing's syndrome, evening cortisol remains elevated, blocking the melatonin rise needed to initiate sleep. A 24-hour urinary free cortisol or late-night salivary cortisol test can confirm pathological evening hypercortisolism.

Low Testosterone in Men

Testosterone deficiency correlates with sleep fragmentation and reduced slow-wave sleep. Reduced androgen signaling alters the regulation of adenosine, a sleep-promoting molecule that accumulates with wakefulness. A 2020 review in the Journal of Clinical Sleep Medicine found that men with moderate-to-severe obstructive sleep apnea had testosterone levels averaging 20-30% below age-matched controls without apnea, though directionality remains debated.

Restless Legs Syndrome and Movement Disorders

Restless Legs Syndrome (RLS)

RLS is a neurological sensorimotor disorder producing an irresistible urge to move the legs, typically worsened at rest and in the evening, which is precisely when sleep onset should occur. The International Restless Legs Syndrome Study Group (IRLSSG) estimates RLS affects 5-10% of the U.S. Population. Most cases are underdiagnosed because patients often cannot clearly describe the sensation, using terms like "crawling," "itching," or "electric" rather than "pain."

Iron deficiency is a direct cause of secondary RLS. A serum ferritin below 75 ng/mL is associated with RLS symptom severity, and the 2018 IRLSSG consensus statement recommends oral or IV iron supplementation as the first step when ferritin is low. Dopaminergic medications (pramipexole, ropinirole) and alpha-2-delta ligands (gabapentin enacarbil) are used when iron repletion alone is insufficient.

Periodic Limb Movement Disorder (PLMD)

PLMD involves repetitive limb movements during sleep, typically every 20 to 40 seconds, that repeatedly pull the brain toward lighter sleep stages. Patients often have no memory of the movements. A bed partner may notice leg kicks. Formal diagnosis requires overnight polysomnography showing a periodic limb movement index above 15 per hour. PLMD shares many of the same treatments as RLS.

Medical Conditions That Impair Sleep Onset

Obstructive Sleep Apnea (OSA)

Most clinicians associate OSA with sleep maintenance problems, but partial airway obstruction during sleep-onset transitions can create enough arousal to prevent stable sleep initiation. OSA affects an estimated 26% of adults aged 30 to 70, according to epidemiological data published in the American Journal of Epidemiology. Snoring, witnessed apneas, or morning headaches in a patient reporting sleep-onset difficulty should prompt an at-home sleep apnea test or laboratory polysomnography.

Chronic Pain

Any condition producing significant pain at rest, including rheumatoid arthritis, fibromyalgia, neuropathy, and low back pain, creates a competing stimulus that prevents the cortical quiet needed for sleep. The relationship runs in both directions: poor sleep lowers pain thresholds through reduced central serotonin and endorphin activity, creating a bidirectional worsening loop.

Gastroesophageal Reflux Disease (GERD)

Lying supine removes gravity's protection against acid reflux. Nocturnal GERD produces microarousals that patients often attribute to "just not being able to sleep." Elevating the head of the bed by 6 to 8 inches and avoiding meals within 3 hours of bedtime are evidence-based first steps. Proton pump inhibitor therapy, taken 30 to 60 minutes before the evening meal, resolves sleep-onset delay in a meaningful subset of patients with undiagnosed GERD.

Medications and Substances That Delay Sleep Onset

At least 30 commonly prescribed medications list insomnia or sleep disturbance as adverse effects. The most clinically significant include:

• Stimulant antidepressants: Bupropion, fluoxetine, and venlafaxine all have activating profiles. Dosing in the morning rather than the evening mitigates much of the sleep-onset effect.
• Beta-blockers: Propranolol crosses the blood-brain barrier and suppresses melatonin production by blocking beta-1 receptors on the pineal gland. Switching to a hydrophilic beta-blocker (atenolol, metoprolol succinate) or adding melatonin 0.5 mg at bedtime may help.
• Corticosteroids: Prednisone at doses above 20 mg/day produces dose-dependent insomnia in a large portion of patients. Morning dosing reduces but does not eliminate the effect.
• Decongestants: Pseudoephedrine and phenylephrine are sympathomimetics that should not be taken after midday in anyone with sleep-onset sensitivity.
• Caffeine: The half-life of caffeine averages 5 to 6 hours but ranges from 2 to 10 hours depending on CYP1A2 genetic variation. A person who metabolizes caffeine slowly may still have active caffeine from a 2 p.m. Coffee at midnight.

Alcohol deserves separate emphasis. It accelerates sleep onset through GABA-A agonism but fragments the second half of sleep through rebound glutamate activity and suppresses REM, producing early-morning awakening even as it initially shortens sleep latency.

Poor Sleep Hygiene and Behavioral Factors

The Role of Sleep Hygiene

Sleep hygiene refers to behavioral and environmental practices that either support or obstruct sleep. Poor sleep hygiene alone rarely causes severe chronic insomnia, but it compounds every other cause on this list. Specific behaviors with strong evidence include:

• Irregular sleep and wake times disrupt circadian entrainment.
• Napping after 3 p.m. Reduces adenosine-driven sleep pressure.
• Room temperature above 68°F (20°C) slows core body cooling, which is a required step for sleep onset.
• High-intensity exercise within 2 hours of bedtime raises core temperature and cortisol.

Stimulus Control: The Most Underused Fix

Stimulus control therapy, developed by Richard Bootzin in 1972, is based on the principle that the bed should be used only for sleep and sex. Reading, watching television, working, or worrying in bed conditions the brain to associate the bedroom with wakefulness. A 2023 meta-analysis in JAMA Internal Medicine found that stimulus control was among the most effective individual CBT-I components, reducing sleep-onset latency by an average of 19 minutes compared to sleep-hygiene education alone.

Diagnosing the Cause: A Practical Clinical Framework

The following stepwise framework is used by the HealthRX medical team to triage patients presenting with sleep-onset insomnia:

Step 1. Rule out red flags. New-onset severe insomnia with mood change, suicidal ideation, or psychotic features warrants same-week psychiatry evaluation, not a sleep protocol.

Step 2. Medication and substance audit. A complete medication and supplement list reviewed for stimulating drugs, caffeine timing, and alcohol use. This step resolves the cause in roughly 15-20% of cases.

Step 3. Circadian pattern history. Ask: What time does the patient feel naturally sleepy? What time do they wake naturally without an alarm? A delayed pattern (sleepy after midnight, rested at 10 a.m.) indicates DSPD. An irregular pattern suggests social jet lag.

Step 4. Targeted labs. TSH, free T4, serum ferritin, CBC, and fasting glucose are the core first-pass panel. In women over 40, FSH, estradiol, and progesterone are added. In men over 35 with fatigue and low libido, total and free testosterone with LH are added.

Step 5. Screen for RLS and OSA. Two validated questions screen for RLS: "Do you have an urge to move your legs at rest, especially at night?" and "Does moving relieve it?" For OSA, the STOP-BANG questionnaire has a sensitivity of 93.3% for moderate-to-severe OSA per a 2008 validation study in Anesthesiology.

Step 6. Sleep diary, two weeks. A prospective two-week sleep diary captures sleep timing, latency, awakenings, alcohol use, and daytime napping far more accurately than patient recall. The Consensus Sleep Diary developed by a NIH-funded workgroup is freely available and takes under two minutes per day.

Step 7. CBT-I referral or digital CBT-I. Before any prescription sleep aid is written, CBT-I should be offered. FDA-cleared digital CBT-I programs (Sleepio, Somryst) produce clinically meaningful reductions in sleep-onset latency within six weeks.

Treatment: Matching Therapy to Cause

CBT-I: The Evidence-Based Standard

The AASM's 2017 clinical practice guideline gives CBT-I a strong recommendation for all adults with chronic insomnia disorder. Across 87 randomized trials, CBT-I reduces sleep-onset latency by a mean of 19 minutes and improves sleep efficiency above 85% in most completers. Unlike medications, benefits persist after treatment ends. The Sleep Foundation's clinical summary of CBT-I evidence is well-aligned with these guideline conclusions.

Pharmacological Options When CBT-I Is Insufficient

When behavioral therapy alone is insufficient, targeted pharmacotherapy is matched to the underlying mechanism:

• Melatonin receptor agonist (ramelteon 8 mg): Best for circadian-driven sleep-onset delay. Non-scheduled, no dependence risk.
• Orexin receptor antagonists (suvorexant 10-20 mg, lemborexant 5-10 mg): Block the wake-promoting orexin system. FDA-approved for sleep-onset and sleep-maintenance insomnia. Lower next-day impairment profile than older sedatives.
• Low-dose doxepin (3-6 mg): FDA-approved specifically for sleep maintenance; less evidence for sleep onset but used off-label when anxiety is a contributor.
• Benzodiazepines and Z-drugs: Effective short-term but carry tolerance, dependence, and next-day cognitive impairment risk. The 2019 American Geriatrics Society Beers Criteria explicitly advises against their use in adults over 65 due to fall and fracture risk.

Hormone Therapy for Perimenopausal Insomnia

For perimenopausal women with vasomotor symptoms driving sleep-onset delay, the Menopause Society states that hormone therapy is the most effective treatment for vasomotor symptoms and their associated sleep disruption. Oral micronized progesterone 100-200 mg at bedtime has the added benefit of direct GABA-A agonism, making it particularly useful for sleep onset compared to synthetic progestins, which lack this receptor activity.